Danielle is a Consultant Medical Oncologist with a specialist interest in urological malignancies. She practices as a Consultant Medical Oncologist at Guy’s Cancer centre and has extensive experience in the management of prostate, renal and other genitourinary cancers, alongside a strong academic background in cancer epidemiology and translational research.

Danielle is also an adjunct Senior Clinical Lecturer at King’s College. Her PhD focused on the relationship between type 2 diabetes and prostate cancer. Her work has contributed significantly to understanding the interplay between metabolic disease and cancer outcomes.

As an accomplished clinical academic, Danielle has authored numerous peer-reviewed publications in leading international journals and has presented her research at major conferences including ESMO, EAU and NCRI. She has several national and international collaborations, including the Metformin and Longevity (METAL) Clinical trial with Cornell University. Her research interests encompass prostate and renal cancer, cancer epidemiology, immuno-oncology and the metabolic consequences of cancer therapies.

Alongside her clinical and research commitments, Dr Crawley is actively involved in medical education, postgraduate supervision. She is also the clinical lead for innovation and technology in the Cancer and Surgery clinical group at Guy’s and St Thomas and is working on various projects to utilise Artificial intelligence within Cancer Multidisciplinary team meetings.